Robert Worsham

Title: Innovations by Robert Worsham in Drug Formulation

Introduction

Robert Worsham is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of drug formulation, particularly in the manufacturing of aminoglycosides. With a total of 3 patents to his name, Worsham's work is pivotal in advancing pharmaceutical manufacturing processes.

Latest Patents

Worsham's latest patents include innovative methods for large-scale manufacturing of drug formulations containing aminoglycosides, such as amikacin. The patented method involves mixing a first stream comprising DPPC and cholesterol with a second stream comprising amikacin sulfate at specific flow rates. This process results in a drug formulation with superior encapsulation efficiency, addressing the need for preparing aminoglycoside drug formulations at a commercial scale. Another notable patent focuses on methods for the continuous manufacture of liposomal drug products. This patent outlines processes for creating liposomal API formulations through continuous in-line diafiltration, enhancing the efficiency of drug production.

Career Highlights

Robert Worsham is currently associated with Insmed Incorporated, a company dedicated to developing innovative therapies for patients with serious diseases. His work at Insmed has been instrumental in pushing the boundaries of drug formulation and manufacturing.

Conclusion

Robert Worsham's contributions to drug formulation and manufacturing are noteworthy, with his innovative patents paving the way for advancements in the pharmaceutical industry. His expertise and dedication continue to impact the field positively.